Genpharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GENPHARM
GENPHARM has four approved drugs.
Drugs and US Patents for Genpharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genpharm | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 077362-001 | Jul 9, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Genpharm | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 075466-004 | Oct 18, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Genpharm | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076476-004 | Feb 11, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

